Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 November 2023 | Story Leonie Bolleurs | Photo Francois van Vuuren
UFS empowers through Human Settlements Training Programme
At the graduation ceremony for the Free State Provincial Department of Human Settlements, were from the left, front: Caren Somiah, Director: Housing Capacity, Building and Partnerships in the Free State Department of Human Settlements; Kagisho Motlhanke, Housing Coordinator at the Mangaung Metro; back: Thomas Stewart, Senior Lecturer in the UFS Department of Urban and Regional Planning; Dr Kgosi Mocwagae, Head of the UFS Department of Urban and Regional Planning; Adv Moferefere Dhlamini, Chief of Staff in the Office of the MEC; Sello Senoge, Matjhabeng Municipality; and Cyril Monyela, Deputy Director-General in the Free State Department of Human Settlements.

The Department of Urban and Regional Planning at the University of the Free State (UFS) hosted a certification ceremony for the Free State Provincial Department of Human Settlements on the Bloemfontein Campus on 30 October 2023.

A group of 40 officials from municipalities and the Provincial Department of Human Settlements were awarded certificates for completing four short learning programmes (SLPs) in Human Settlements, offered by the Department of Urban and Regional Planning. The training was conducted between November 2022 and May 2023.

Sustainable human settlements

“The overall aim of this training was to equip the participants to play a constructive role in human settlements in their respective places of employment,” said Dr Kgosi Mocwagae, Head of the Department of Urban and Regional Planning at the UFS. 

This is in line with the mission of the department to deliver – through excellent teaching and scholarship – competent urban and regional planners who will contribute to the creation of sustainable human settlements and improve the quality of life, particularly in Africa.

Dr Mocwagae reflected on the training presented, stating that it aimed to achieve several key objectives, including enhancing participants' understanding of the institutional framework governing the development and management of human settlements. It also sought to nurture a sensitivity to the principles of sustainable human settlement development, considering factors such as climate change, the Sustainable Development Goals (SDGs), local legislation, and best practices. Additionally, the training placed significant emphasis on the importance and processes involved in upgrading informal settlements. Furthermore, it aimed to empower participants with the necessary skills to structure a proposal for the enhancement of informal settlements within the current legislative and administrative frameworks applicable in South Africa.

Building capacity

Cyril Monyela, the Deputy Director General in the Free State Department of Human Settlements, delivered the keynote address, congratulating the cohort of officials on their remarkable achievement.

In his address, he referred to the various pieces of legislation that have emerged over the years and emphasised the need for capacity to implement human settlement sector programmes, ensuring that millions of informal households in South Africa have access to decent shelter. Enhancing sector capacity by developing the skills of staff is one of the department's primary institutional objectives.

“It is the first of many skills courses designed to enable and ensure that practitioners in the Free State Department of Human Settlements execute the department’s mandate,” he stated.

The event concluded with an address from Advocate Shirly Hyland, Director of the Kovsie Phahamisa Academy. According to her, it is important to remember where one comes from, but it is also key to focus on our future. “Witnessing plans that originated in the 1950s coming to fruition, while not perfect yet, is encouraging and instils hope in South Africans regarding the progress being made,” she remarked. 

Adv Hyland referenced a quote from a corporate giant, ‘You are not your work, and your work is not you.’ “For you, this is not the case. Those of you who work in human settlements – your work literally follows you home. Human settlements affect every person from every sphere of life. The right to adequate housing is enshrined in the Bill of Rights, and with the expertise you have learned in these programmes, you have been equipped with the knowledge and power to bring this human right to life.”

“In completing this short learning programme, you have been entrusted with a critical task. You get to contribute to an environment in which citizens live and thrive. The environment where a veggie garden can feed a community; the environment in which the Protea or Bafana Bafana national teams can nurture their talents; and the environment in which the leaders of tomorrow are born and raised,” she said. 

In her final remarks, Adv Hyland referred to a quote from former President Nelson Mandela about education being the most powerful weapon one can use to change the world. “And this is exactly what you are doing. You have worked hard,” she said, urging the group of practitioners to change the world, one human settlement at a time. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept